-

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Blucora, Inc. Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Blucora, Inc. (“Blucora” or the “Company”) (NASDAQ: BCOR) investors concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On January 16, 2020, Blucora revealed that its President and Chief Executive Officer (“CEO”), John Clendening, “has departed his roles as executive and member of the Board of Directors” and that Blucora “anticipates announcing a new CEO by the end of January 2020.” Blucora specified that Clendening’s “departure results from differences in views on the scope of Mr. Clendening’s authority as CEO.”

On this news, Blucora’s stock price fell $1.57, or over 6%, to close at $22.94 per share on January 16, 2020, thereby injuring investors.

If you purchased Blucora securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles H. Linehan, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9224, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay and Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
www.glancylaw.com
shareholders@glancylaw.com

Glancy Prongay & Murray LLP

NASDAQ:BCOR

Release Summary
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Blucora, Inc. Investors
Release Versions
$Cashtags

Contacts

Glancy Prongay and Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
www.glancylaw.com
shareholders@glancylaw.com

More News From Glancy Prongay & Murray LLP

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Picard Medical, Inc. (PMI) Shareholders to Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Picard Medical, Inc. (“Picard” or the “Company”) (NYSE American: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages China Liberal Education Holdings Limited (CLEUF) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired China Liberal Education Holdings Limited (“CLEU” or the “Company”) (OTC: CLEUF) securities between January 22, 2025 and January 30, 2025, inclusive (the “Class Period”). CLEU investors have until March 31, 2026 to file a lead plaintiff motion. IF YOU SU...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Plug Power, Inc. (PLUG) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Plug Power, Inc. (“Plug Power” or the “Company”) (NASDAQ: PLUG) securities between January 17, 2025 and November 13, 2025, inclusive (the “Class Period”). Plug Power investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A L...
Back to Newsroom